Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation

Michaël R. Paillasse, Céline Deraeve, Philippe de Medina, Loubna Mhamdi, Gilles Favre, Marc Poirot and Sandrine Silvente-Poirot
Molecular Pharmacology December 2006, 70 (6) 1935-1945; DOI: https://doi.org/10.1124/mol.106.029967
Michaël R. Paillasse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Céline Deraeve
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe de Medina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loubna Mhamdi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Favre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Poirot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrine Silvente-Poirot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The cholecystokinin (CCK) 2 receptor (CCK2R) appears as a pharmacological target for the treatment of many major diseases. To complete the mapping of the CCK2R binding site and its activation processes, we have looked for the receptor residues that interact with Trp6, an essential residue for CCK binding and activity. In our molecular model of the CCK-occupied CCK2R, the indole group of Trp6 stacked with the phenyl ring of Phe120 (ECL1) and interacted with the imidazole group of His381(H7.39) and the phenyl ring of Tyr385(H7.43). Mutagenesis and pharmacological studies validated these interactions. It is noteworthy that the mutation of Phe120 to Trp conferred constitutive activity to the CCK2R. Molecular modeling and experimental works identified the residues involved in the activation cascade initiated by Trp6 and revealed that the constitutively active F120W mutation mimics the conformational changes induced by Trp6 resulting in: 1) the exposure of Glu151(E3.49) of the conserved E/DRY motif 2) the formation of an amphiphatic pocket involving protonated Glu151(E3.49) and Leu330 (ICL3), and 3) the opening of the intracellular loops 2 and 3 and the release of Arg158 (ICL2). The R158A mutation was shown to affect inositol phosphate production, whereas the E151A and L330E mutations induced constitutive inositol phosphate production. Given that a constitutively active variant of the CCK2R has been identified in different cancers and the fact that the E151A mutant has been reported to induce tumors, these studies should help in the development of potent inverse agonists to inhibit the constitutive activation of the CCK2R.

Footnotes

  • This work was supported by the INSERM, AFFICHEM, Institut Claudius Regaud, and the French Ministry of Education and Research. S.S.P. is in charge of research for the Centre National de la Recherche Scientifique.

  • ABBREVIATIONS: CCK, cholecystokinin; CCK2R, cholecystokinin 2 receptor; CCK-9s, sulfated CCK nonapeptide; ECL, extracellular loop; ICL, intracellular loop; WT, wild type; TM, transmembrane; IP, inositol phosphate; PLC, phospholipase C; ECL, extracellular loop; TM, transmembrane domains; RPR048, 2-{3-[3-({(3-methoxy-phenyl)-[(methyl-phenyl-carbamoyl)-methyl]-carbamoyl}-methyl)-ureido]-phenyl}-propionic acid; DMEM, Dulbecco's modified Eagle's medium; IP, inositol phosphate; BSA, bovine serum albumin; PD140376, l-3-[(4-aminophenyl)methyl]-N-[α-methyl-N-[(tricyclo[3.3.1.13,7]dec-2-yloxy)-carbonyl]-d-tryptophyl]-β-alanine.

  • ↵1 MRP and CD contributed equally to this work.

    • Received August 14, 2006.
    • Accepted September 22, 2006.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 70 (6)
Molecular Pharmacology
Vol. 70, Issue 6
1 Dec 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation

Michaël R. Paillasse, Céline Deraeve, Philippe de Medina, Loubna Mhamdi, Gilles Favre, Marc Poirot and Sandrine Silvente-Poirot
Molecular Pharmacology December 1, 2006, 70 (6) 1935-1945; DOI: https://doi.org/10.1124/mol.106.029967

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation

Michaël R. Paillasse, Céline Deraeve, Philippe de Medina, Loubna Mhamdi, Gilles Favre, Marc Poirot and Sandrine Silvente-Poirot
Molecular Pharmacology December 1, 2006, 70 (6) 1935-1945; DOI: https://doi.org/10.1124/mol.106.029967
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics